—

Paradigm Biocapital Advisors LP

Q1 2026 13F Holdings

  • Location
    new york, NY
  • Num holdings

    35

  • Value ($000)

    $4,894,262

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0001855655
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
A
ACLX

ARCELLX INC

COMMON STOCK
03940C100
$662.97M
14 %

5,774,016

R
RVMD

REVOLUTION MEDICINES INC

COM
76155X100
$647.27M
13 %

6,655,703

N
NUVL

NUVALENT INC

COM
670703107
$545.49M
11 %

5,324,433

P
PCVX

VAXCYTE INC

COM
92243G108
$278.52M
6 %

4,793,020

E
EWTX

EDGEWISE THERAPEUTICS INC

COM
28036F105
$232M
5 %

7,365,038

G
GMAB

GENMAB A/S

SPONSORED ADS
372303206
$213.78M
4 %

7,967,836

I
INSM

INSMED INC

COM PAR $.01
457669307
$205.13M
4 %

1,254,488

T
TARS

TARSUS PHARMACEUTICALS INC

COM
87650L103
$179.74M
4 %

2,562,154

B
BLTE

BELITE BIO INC

SPONSORED ADS
07782B104
$177.74M
4 %

1,114,784

E
ERAS

ERASCA INC

COM
29479A108
$168.15M
3 %

10,392,702

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 35